Raymond James Financial Lowers kneat.com (TSE:KSI) Price Target to C$7.00

Key Points

• Raymond James Financial has lowered its price target for kneat.com from C$7.50 to C$7.00 while maintaining an "outperform" rating, indicating a potential upside of 25.67% from the previous close.
• On the day of the announcement, kneat.com shares fell to C$5.57 with a trading volume significantly above its average, reflecting heightened market activity.
• kneat.com is focused on developing software for regulated industries, particularly in the life sciences, and offers its Kneat Gx solution for enhanced product and quality management.

kneat.com (TSE:KSI - Free Report) had its price objective reduced by Raymond James Financial from C$7.50 to C$7.00 in a report issued on Wednesday,BayStreet.CA reports. They currently have an outperform rating on the stock. Raymond James Financial also issued estimates for kneat.com's Q3 2025 earnings at ($0.03) EPS, Q4 2025 earnings at ($0.03) EPS, FY2025 earnings at ($0.04) EPS and FY2026 earnings at ($0.05) EPS.

kneat.com Trading Down 1.8%

Shares of TSE:KSI traded down C$0.11 on Wednesday, hitting C$5.91. The company had a trading volume of 540,740 shares, compared to its average volume of 92,602. kneat.com has a 1 year low of C$4.40 and a 1 year high of C$7.25. The firm has a market capitalization of C$552.59 million, a price-to-earnings ratio of -63.84, a P/E/G ratio of 597.67 and a beta of 1.08. The firm's 50-day simple moving average is C$6.04 and its two-hundred day simple moving average is C$6.27. The company has a quick ratio of 1.50, a current ratio of 1.43 and a debt-to-equity ratio of 85.50.

kneat.com Company Profile

kneat.com Inc is in the business of developing and marketing a software application for modelling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance.